Anakinra's Effects on COVID-19 Outcomes
Sporadic reports of anakinra use in COVID-19 infection has hinted is potential; now a metanalysis…
View Resource
EULAR 2023 Notes from Milan (6.09.2023)
Dr. Jack Cush reviews highlight abstracts and sessions – covering lupus, RA, gout, Still’s…
View Resource
Sniffles & Arthritis (3.1.2024)
Dr. Jack Cush reviews the news and journal reports from the past week on…
View Resource
ACR 2024 – Day 2 Report
Plenary sessions began the day, followed by thousands on the abstract floor. Here are…
View Resource
Tocilizumab Risk of Diverticulitis and GI Perforation
A French registry analysis compared the risk of diverticulitis and gastrointestinal perforation (GIP) in…
View Resource
JAK Inhibitors in Difficult Still’s Disease
A small retrospective study suggests that patients with difficult to treat adult-onset Still’s disease…
View Resource
Heavy Metal Rheumatology (9.23.2022)
Thanks to all of you for your kind comments and great reviews of our…
View Resource
ICYMI: LAVLI – A New Autoinflammatory Disorder
Editor’s note: This article originally appeared March 28, 2023, and is being shared again…
View Resource
Depression and RA (3.8.2024)
Dr. Jack Cush reviews the news, journal reports and regulatory approvals from the past…
View Resource
Rhapsody Study: IL-1 Inhibition in Recurrent Pericarditis
Recurrent pericarditis is a rare, probable autoinflammatory disorder mediated by interleukin-1 (IL-1); and is often…
View Resource